| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 02/10/2005 | US20050031899 Carbazole derivative, organic semiconductor element, light emitting element, and electronic device |
| 02/10/2005 | CA2534893A1 A novel process for the manufacture of (+)-(s)-clopidogrel bisulfate form-i |
| 02/10/2005 | CA2534649A1 Bicyclic imidazol derivatives against flaviviridae |
| 02/10/2005 | CA2534460A1 Benzylamine derivative |
| 02/10/2005 | CA2534263A1 Phenylazole compounds, production process and antioxidants |
| 02/10/2005 | CA2534212A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 02/10/2005 | CA2534038A1 Inhibitors of akt activity |
| 02/10/2005 | CA2533774A1 Compounds and compositions as protein kinase inhibitors |
| 02/10/2005 | CA2532965A1 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 02/10/2005 | CA2531291A1 Pyrazoloisoquinoline derivatives as kinase inhibitors |
| 02/10/2005 | CA2520546A1 Benzo[1,2,5]thiadiazole compounds |
| 02/09/2005 | EP1505061A1 Compound exhibiting pgd 2 receptor antagonism |
| 02/09/2005 | EP1504040A1 Method for reduction of residual organic solvent in carbomer |
| 02/09/2005 | EP1504008A1 7-aminoimidazotriazones |
| 02/09/2005 | EP1504003A1 Nitrosated imidazopyridines |
| 02/09/2005 | EP1503760A1 Camptothecin derivatives and polymeric conjugates thereof |
| 02/09/2005 | EP1503757A2 Tyrosine kinase inhibitors |
| 02/09/2005 | EP1385854B1 Thiazolopyrimidines and their use as modulators of chemokine receptor activity |
| 02/09/2005 | EP1339717B1 Novel carbamate-substituted pyrazolopyridine derivatives |
| 02/09/2005 | EP1292269B1 Agent for dyeing keratin containing fibers |
| 02/09/2005 | EP1100789B1 Substituted benzoylcyclohexandiones |
| 02/09/2005 | CN1578781A 1, 8 naphthyridine derivatives and their use to treat diabetes and related disorders |
| 02/09/2005 | CN1578780A 1, 6-naphthyridine derivatives as antidiabetics and pharmaceutical compositions containing them |
| 02/09/2005 | CN1578773A Methods and compositions of novel triazine compounds |
| 02/09/2005 | CN1578661A Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 02/09/2005 | CN1578660A Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 02/09/2005 | CN1575816A Compounds for the treatment of female sexual dysfunction |
| 02/09/2005 | CN1188414C Method of stabilizing aqueous pyrazoloacridone derivative solution |
| 02/09/2005 | CN1188413C Compound for treatment of pain |
| 02/09/2005 | CN1188412C Process for preparing crystalline form 1 of cabergoline |
| 02/08/2005 | US6852861 Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via 1H-imidazo [4,5-C] quinolin-4-phthalimide intermediates |
| 02/08/2005 | US6852855 Synthesis of piperazine ring |
| 02/08/2005 | US6852745 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 02/08/2005 | US6852734 Indole wherein A is an oxygen atom or a nitrogen atom which nitrogen atom is optionally substituted with an alkyl group, and (i) R1 and R2 each stand for a hydrogen atom or an alkyl group, independently, or (ii) R1 and R2 as taken together form |
| 02/08/2005 | US6852732 A tetrahydropyridino or piperidino heterocyclic derivative represented by the formula (I): has a high affinity for CRF receptors and is effective against diseases in which CRF is considered to be involved. (Corticotropin releasing factor |
| 02/08/2005 | US6852730 Substituted fused pyrazolecarboxylic acid arylamides and related compounds |
| 02/08/2005 | US6852727 Inhibitors of Janus protein tyrosine kinases (Jak), and as such are useful as immunosuppressants, and in the treatment of diseases including asthma, allergies, autoimmune diseases. |
| 02/08/2005 | US6852725 Imidazolyl derivatives |
| 02/08/2005 | US6852722 Administering a growth hormone secretagogue. |
| 02/08/2005 | US6852721 Compounds capable of activating nicotinic cholinergic receptors; N-aryl diazabicyclic compounds such as (1S,4S)-2-(5-(3-methoxyphenoxy)-3-pyridyl)-2,5-diazabicyclo(2. 2.1)-heptane; treating central nervous system disorders |
| 02/08/2005 | US6852716 Central nervous system disorders; psychological disorders |
| 02/08/2005 | US6852712 Controlling cell differentiation; antiinflammatory agents |
| 02/08/2005 | CA2287316C Process for preparing 6-o-monoesters of castanospermine |
| 02/03/2005 | WO2005010003A1 Sulfonyldihydroimid- azopyridinone compounds as 5-hydroxytryptamine-6 ligands |
| 02/03/2005 | WO2005010002A1 Process for the synthesis of zolpidem |
| 02/03/2005 | WO2005010001A1 Nicotinamide derivatives useful as pdea4 inhibitors |
| 02/03/2005 | WO2005010000A2 Aryl-condensed 3-arylpyridine compounds and use thereof for controlling pathogenic fungi |
| 02/03/2005 | WO2005009995A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | WO2005009994A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | WO2005009978A1 2-aminopyrimidine and 2-aminopyridine-4-carbamates for use in the treatment of autoimmune diseases |
| 02/03/2005 | WO2005009967A2 Quinolinone derivatives as inhibitors of c-fms kinase |
| 02/03/2005 | WO2005009962A1 Hydroxypyridine cgrp receptor antagonists |
| 02/03/2005 | WO2005009958A1 Ppar active compounds |
| 02/03/2005 | WO2005009947A2 Aryl heteroaromatic products, compositions comprising the same and use thereof |
| 02/03/2005 | WO2005009398A2 Tetracyclic benzamide derivatives and methods of use thereof |
| 02/03/2005 | WO2005009389A2 Anaplastic lymphoma kinase modulators and methods of use |
| 02/03/2005 | WO2005009370A2 Beta-carboline compounds and analogues thereof and their use as mitogen-activated protein kinase-activated protein kinase-2 inhibitors |
| 02/03/2005 | WO2004101565A3 Jnk inhibitors |
| 02/03/2005 | WO2004054581A3 Cyclohexyl compounds as ccr5 antagonists |
| 02/03/2005 | WO2003106450A8 Phenylaminopyrimidines and their use as rho-kinase inhibitors |
| 02/03/2005 | US20050027130 Rhodamine dye compounds for patterns with DNA sequences for kits |
| 02/03/2005 | US20050027122 Compounds for modulators of chemokine activity |
| 02/03/2005 | US20050026947 1H-imidazo dimers |
| 02/03/2005 | US20050026946 GSK-3 inhibitors |
| 02/03/2005 | US20050026942 Chemokine receptor binding heterocyclic compounds |
| 02/03/2005 | US20050026941 preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase used for prophylaxis of erectile dysfunction and cardiovascular disorders |
| 02/03/2005 | US20050026929 2-Phenyl-4-(piperidin-1-ylcarbonyl)-oxazole derivatives; capsase activators; cancer, autoimmune diseases, rheumatoid arthritis, inflammatory bowel disease, or psoriasis |
| 02/03/2005 | US20050026925 1,2,3,4,9,9a-Hexahydro-2,4a,5-triaza-fluorene derivatives for obesity treatment |
| 02/03/2005 | US20050026922 For treating CNS or other disorders, including concurrent treatment of disorders such as schizophrenia and depression; side effect reduction; for example, (7R,9aS)-trans-7-[6-(2,6-Dimethyl-piperidin-1-ylmethyl)-pyridin-2-yloxymethyl]-2-(5-fluoro-benzo[d]isoxazol-3-yl)-octahydro-pyrido[1,2-a]pyrazine |
| 02/03/2005 | US20050026921 New imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 02/03/2005 | US20050026917 Tricyclic indanyls as integrin inhibitors |
| 02/03/2005 | US20050026915 As melanin concentrating hormone (MCH)receptor antagonists, for prevention or treatment of obesity or eating disorders; (2E)-3-(4-chlorophenyl)-N-[2-(dimethylamino)quinolin-6-yl]prop-2-enamide |
| 02/03/2005 | US20050026914 Pyrimidine or pyridine carbamate compounds as for example 1,1-dimethylethyl 4-(4-((4-((((2,6-dimethylphenyl)oxy)carbonyl)(4-(methyloxy)phenyl)amino)-2-pyrimidinyl)amino)phenyl)-1-piperazinecarboxylate; for the treatment of protein tyrosine kinase-associated disorders |
| 02/03/2005 | US20050026901 Antihistaminic spiro compounds |
| 02/03/2005 | US20050026174 Alternative heterocycles for DNA recognition |
| 02/03/2005 | DE10330358A1 New arylalkanol derivatives used for treating e.g. respiratory diseases, joint diseases, vascular inflammations, skin disorders, kidney and liver diseases and neurological diseases |
| 02/03/2005 | CA2536383A1 Nicotinamide compounds useful as pde4 inhibitors |
| 02/03/2005 | CA2533681A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | CA2533626A1 Quinolinone derivatives as inhibitors of c-fms kinase |
| 02/03/2005 | CA2533624A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | CA2533494A1 Aryl heteroaromatic products, compositions comprising the same and use thereof |
| 02/03/2005 | CA2532980A1 2-aminopyrimidine and 2-aminopyridine-4-carbamates for use in the treatment of autoimmune diseases |
| 02/03/2005 | CA2532917A1 Aryl-condensed 3-arylpyridine compounds and use thereof for controlling pathogenic fungi |
| 02/03/2005 | CA2532800A1 Anaplastic lymphoma kinase modulators and methods of use |
| 02/03/2005 | CA2532403A1 Ppar active compounds |
| 02/03/2005 | CA2532249A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | CA2532076A1 Sulfonyldihydroimid- azopyridinone compounds as 5-hydroxytryptamine-6 ligands |
| 02/03/2005 | CA2532064A1 Hydroxypyridine cgrp receptor antagonists |
| 02/03/2005 | CA2517260A1 Tetracyclic benzamide derivatives and methods of use thereof |
| 02/02/2005 | EP1502917A1 Use of mono- and dicationic naphthalene-based imide dyes in optical layers for optical data recording |
| 02/02/2005 | EP1501841A2 Non nucleoside reverse transcriptase inhibitors |
| 02/02/2005 | EP1501830A1 7-aryl-3,9-diazabicyclo[3.3.1]non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases |
| 02/02/2005 | EP1501827A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acid and their use as protease inhibitors |
| 02/02/2005 | EP1501507A2 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
| 02/02/2005 | EP1390365B1 Novel sulfonate substituted pyrazol pyridine dervivatives |
| 02/02/2005 | EP1373267B1 Non-nucleoside reverse transcriptase inhibitors |
| 02/02/2005 | EP1137413B1 Non-peptide antagonists of glp-1 receptor and methods of use |
| 02/02/2005 | EP0828754B1 Dipeptides which promote release of growth hormone |
| 02/02/2005 | CN1575289A 6-hydroxy isoflavon compounds, their derivatives and medicaments involving the same |
| 02/02/2005 | CN1575177A Cxcr3 antagonists |